IQVIA Holdings Inc. (IQV)

115.46
NYSE : Health Services
Prev Close 115.46
Day Low/High 0.00 / 0.00
52 Wk Low/High 91.57 / 135.48
Avg Volume 1.33M
Exchange NYSE
Shares Outstanding 198.05M
Market Cap 22.91B
EPS 6.00
P/E Ratio 20.36
Div & Yield N.A. (N.A)

Latest News

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment...

IQVIA's OCE Technology Platform Selected By Napo Pharmaceuticals To Increase Commercial Efficiency

IQVIA's OCE Technology Platform Selected By Napo Pharmaceuticals To Increase Commercial Efficiency

IQVIA™ (NYSE:IQV) today announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, Inc.

IQVIA Holdings Becomes #121 Most Shorted S&P 500 Component, Replacing NextEra Energy

IQVIA Holdings Becomes #121 Most Shorted S&P 500 Component, Replacing NextEra Energy

The most recent short interest data has been released for the 11/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IQVIA's Orchestrated Customer Engagement Selected By Novo Nordisk International Operations

IQVIA's Orchestrated Customer Engagement Selected By Novo Nordisk International Operations

IQVIA™ (NYSE:IQV) today announced that Novo Nordisk, a global healthcare company with nearly a century of innovation and leadership in diabetes care, has selected IQVIA's market-leading Orchestrated Customer Engagement platform for deployment across Novo...

Adhera Therapeutics Selects IQVIA's OCE Technology Platform To Support Commercial Excellence

Adhera Therapeutics Selects IQVIA's OCE Technology Platform To Support Commercial Excellence

IQVIA™ (NYSE:IQV) today announced that Adhera Therapeutics Inc. (OTCQB:ATRX) has selected Orchestrated Customer Engagement (OCE), IQVIA Technologies' transformational commercial platform, to build its commercial infrastructure and bring the company's...

See How IQVIA Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How IQVIA Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that IQVIA Holdings Inc is the #16 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

IQVIA Launches Digital ICF Author, A SaaS EConsent Tool To Transform The Informed Consent Process

IQVIA Launches Digital ICF Author, A SaaS EConsent Tool To Transform The Informed Consent Process

IQVIA™ (NYSE:IQV) announced today the launch of Informed Consent Form (ICF) Author, a SaaS eConsent tool for use in clinical trials.

IQVIA To Present At The Credit Suisse Annual Healthcare Conference On November 13, 2018

IQVIA To Present At The Credit Suisse Annual Healthcare Conference On November 13, 2018

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Credit Suisse 27th Annual Healthcare Conference in Scottsdale, AZ on Tuesday, November 13, 2018 at...

IQVIA Holdings Becomes #192 Most Shorted S&P 500 Component, Replacing Illinois Tool Works

IQVIA Holdings Becomes #192 Most Shorted S&P 500 Component, Replacing Illinois Tool Works

The most recent short interest data has been released for the 10/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IQVIA Reports Third-Quarter 2018 Results And Updates Full-Year 2018 Guidance

IQVIA Reports Third-Quarter 2018 Results And Updates Full-Year 2018 Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2018.

IQVIA's Commercial Technology Suite For Global Deployment Selected By Roche

IQVIA's Commercial Technology Suite For Global Deployment Selected By Roche

IQVIA (NYSE: IQV) today announced that the pharmaceuticals division of Roche (F.

IQVIA To Announce Third-Quarter 2018 Results On October 22, 2018

IQVIA To Announce Third-Quarter 2018 Results On October 22, 2018

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), will announce its third-quarter 2018 financial results before the market opens on Monday, October 22, 2018.

IQVIA And Genomics England Launch The First Real-World Research Platform With Integrated Clinical And Genomic Data

IQVIA And Genomics England Launch The First Real-World Research Platform With Integrated Clinical And Genomic Data

IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients.

IQVIA To Build Clinically-Focused Tech Solutions Suite For Life Sciences On Salesforce Health Cloud

IQVIA To Build Clinically-Focused Tech Solutions Suite For Life Sciences On Salesforce Health Cloud

IQVIA (NYSE: IQV) today announced the expansion of its alliance with Salesforce, the global leader in CRM and provider of Software as a Service (SaaS) solutions, to build a clinical solution for life sciences on Salesforce Health Cloud.

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that IQVIA Holdings Inc is the #16 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

Theramex Chooses IQVIA's Orchestrated Customer Engagement

Theramex Chooses IQVIA's Orchestrated Customer Engagement

IQVIA™ (NYSE: IQV), a company dedicated to applying advanced analytics and technology in healthcare to help clients find better solutions for patients, and Theramex, an international pharmaceutical company dedicated to women's health, today announced a...

Medytox Selects IQVIA's Enterprise Quality Management Platform, Including SmartSolve®, For Quality And Compliance Management

Medytox Selects IQVIA's Enterprise Quality Management Platform, Including SmartSolve®, For Quality And Compliance Management

IQVIA™ (NYSE: IQV) today announced that the global biopharmaceutical company Medytox has selected IQVIA's Enterprise Quality Management Solutions (EQMS) platform for quality and compliance management.

IQVIA's Jon Resnick Honored On 2018 PharmaVOICE 100 List

IQVIA's Jon Resnick Honored On 2018 PharmaVOICE 100 List

IQVIA (NYSE:IQV) today announced that Jon Resnick, IQVIA's president, Real-World & Analytics Solutions, has been named to PharmaVOICE magazine's annual list of the 100 most influential and inspiring individuals within the life sciences industry.

IQVIA Holdings Becomes #193 Most Shorted S&P 500 Component, Replacing Xylem

IQVIA Holdings Becomes #193 Most Shorted S&P 500 Component, Replacing Xylem

The most recent short interest data has been released for the 07/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IQVIA Reports Second-Quarter 2018 Results And Raises Full-Year 2018 Revenue And Profit Guidance

IQVIA Reports Second-Quarter 2018 Results And Raises Full-Year 2018 Revenue And Profit Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2018.

IQVIA To Announce Second-Quarter 2018 Results On July 24, 2018

IQVIA To Announce Second-Quarter 2018 Results On July 24, 2018

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), will announce its second-quarter 2018 financial results before the market opens on Tuesday, July 24, 2018.

IQVIA Launches A Transformative Suite Of Virtual Research Solutions

IQVIA Launches A Transformative Suite Of Virtual Research Solutions

IQVIA (NYSE:IQV) announced today the launch of Virtual Research Solutions, a new suite of technology-led study options offering advances in patient-centric trial design and execution.

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that IQVIA Holdings Inc is the #51 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment...

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment...

IQVIA Announces Senior Secured Credit Facility Transaction To Refinance Existing Indebtedness

IQVIA Announces Senior Secured Credit Facility Transaction To Refinance Existing Indebtedness

IQVIA Inc., a wholly-owned subsidiary of IQVIA Holdings Inc.

IQVIA Launches Commercial Content Management Solution IQVIA™ EPromo

IQVIA Launches Commercial Content Management Solution IQVIA™ EPromo

IQVIA (NYSE:IQV), a company dedicated to applying advanced analytics and technology to help healthcare clients find better solutions for patients, today announced the launch of IQVIA™ ePromo, a new cloud-based content management technology solution.

IQVIA™ Institute For Human Data Science Study: Spending On Cancer Meds In The U.S. Doubled From 2012-2017 - Expected To Double Again By 2022 To $100 Billion

IQVIA™ Institute For Human Data Science Study: Spending On Cancer Meds In The U.S. Doubled From 2012-2017 - Expected To Double Again By 2022 To $100 Billion

The IQVIA™ Institute for Human Data Science found in its latest report, Global Oncology Trends 2018: Innovation, Expansion and Disruption, that spending on cancer drugs in the U.

TheStreet Quant Rating: B (Buy)